Literature DB >> 3689666

Confirmation of a prognostic index in primary breast cancer.

J H Todd1, C Dowle, M R Williams, C W Elston, I O Ellis, C P Hinton, R W Blamey, J L Haybittle.   

Abstract

A prognostic index, previously derived in a group of 387 patients with primary breast cancer, has been recalculated for the same patients with over 5 years further follow-up and shown to be unchanged. The prognostic index has also been applied prospectively to a further group of 320 patients and shown to be similarly effective in identifying patients with either a very good or a very poor prognosis. It has been verified that the index applies to patients with primary breast cancer. Patients have now been divided into 5 prognostic groups, predicting 11% of patients with an almost normal survival and a further 10% with a very poor prognosis. The index is used to stratify patients to study the effects of treatment regimes within groups of similar patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689666      PMCID: PMC2001834          DOI: 10.1038/bjc.1987.230

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  6 in total

1.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

2.  The prediction of local or regional recurrence after simple mastectomy for operable breast cancer.

Authors:  M R Williams; C P Hinton; J H Todd; D A Morgan; C W Elston; R W Blamey
Journal:  Br J Surg       Date:  1985-09       Impact factor: 6.939

3.  Relationship between primary breast tumor receptor status and patient survival.

Authors:  R W Blamey; H M Bishop; J R Blake; P J Doyle; C W Elston; J L Haybittle; R I Nicholson; K Griffiths
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

4.  Subcutaneous mastectomy for primary operable breast cancer.

Authors:  C P Hinton; P J Doyle; R W Blamey; C J Davies; H W Holliday; C W Elston
Journal:  Br J Surg       Date:  1984-06       Impact factor: 6.939

5.  A prognostic index in primary breast cancer.

Authors:  J L Haybittle; R W Blamey; C W Elston; J Johnson; P J Doyle; F C Campbell; R I Nicholson; K Griffiths
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

6.  The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.

Authors:  C W Elston; G A Gresham; G S Rao; T Zebro; J L Haybittle; J Houghton; G Kearney
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

  6 in total
  84 in total

Review 1.  Preoperative assessment of prognostic factors in breast cancer.

Authors:  H Denley; S E Pinder; C W Elston; A H Lee; I O Ellis
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  The Nottingham Prognostic Index: five- and ten-year data for all-cause survival within a screened population.

Authors:  Y Fong; J Evans; D Brook; J Kenkre; P Jarvis; K Gower-Thomas
Journal:  Ann R Coll Surg Engl       Date:  2015-03       Impact factor: 1.891

4.  Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women.

Authors:  Mg Mostafa; Mt Larsen; Rr Love
Journal:  J Bangladesh Coll Phys Surg       Date:  2010

5.  Treating elderly patients with breast cancer.

Authors:  K Dookeran; A Stotter; R Windle; R Walker
Journal:  BMJ       Date:  1992-05-23

6.  Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.

Authors:  Neha Bhooshan; Maryellen L Giger; Sanaz A Jansen; Hui Li; Li Lan; Gillian M Newstead
Journal:  Radiology       Date:  2010-02-01       Impact factor: 11.105

7.  Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer.

Authors:  Maura Bríd Cotter; Alex Dakin; Aoife Maguire; Janice M Walshe; M John Kennedy; Barbara Dunne; Ciarán Ó Riain; Cecily M Quinn
Journal:  Virchows Arch       Date:  2017-07-14       Impact factor: 4.064

8.  Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer.

Authors:  P Shrestha; K Yamada; T Wada; S Maeda; M Watatani; M Yasutomi; H Takagi; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.

Authors:  H E Campbell; M A Taylor; A L Harris; A M Gray
Journal:  Br J Cancer       Date:  2009-09-01       Impact factor: 7.640

10.  PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.

Authors:  Gordon C Wishart; Elizabeth M Azzato; David C Greenberg; Jem Rashbass; Olive Kearins; Gill Lawrence; Carlos Caldas; Paul D P Pharoah
Journal:  Breast Cancer Res       Date:  2010-01-06       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.